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Rapid, Diagnostic Test for Cardiac Ischemia
Background

Innovation

Performance

Chest pain is the second most common reason Americans visit
the emergency room, which amounts to 7-8 million visits each
year [1]. These visits are often because when chest pain
ensues, the first thing people think is heart attack. However,
several factors can cause chest pain, such as stress and
panic attacks.
A heart attack, or myocardial infarction, occurs when blood flow
to the heart is restricted, often by a blood clot (Figure 1).
Before the onset of a heart attack, myocardial ischemia, which
is an inadequate blood supply to the heart, can occur.

New Assay:

Luminescence:

•

•

A VCU patented chemiluminescent assay [2] uses xanthine oxidase (XO)
activity in a microliter sample of blood to detect biomarkers inosine and
hypoxanthine indicative of myocardial ischemia (Figure 2). Prolonged and
untreated ischemia leads to infarction.
Metabolic byproducts of XO activity is detectable within minutes of an
ischemic event.

Comparing results from a single
well in 12 well plate (SA = 4 cm2)
to the spiral on chip (SA = 6 cm2),
a 5 fold increase, as shown in
Figure 4, in luminescence
intensity was measured from 0.2 mL
of luminol at a concentration of
24 mg/mL.
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Figure 4. Luminol reading from 12 well plate and lab-on-chip.
Inosine

Figure 2. Principle of the chemiluminescent ischemia bioassay.

Objective:
•

To build a point-of-care device to screen for cardiac ischemia using the
VCU patented assay.

Future Improvements
•
•
•
•
•

Design Criteria:
Figure 1. Coronary events that can lead to ischemia.

Problem
Current tests for myocardial infarction use the biomarker,
troponin, for diagnosis. Diagnostic levels of troponin are
observed hours after the event.

• Rapid (less than 10 minutes) analysis time
• Sensitive (20µL plasma sample) and specific to inosine and hypoxanthine
• Portable (handheld) device

Potential users:
•
•
•

Hospital/clinic personnel
Emergency Medical Services (EMS) personnel
Patients testing at home

Design Approach:
•

Diagnosis of infarction via troponin:
1. Prolonged myocardial ischemia
2. Myocardial infarction
3. Ambulance to ER
4. Treatment (hours wait for troponin test)
5. Confirmed diagnosis
6. Further treatment
There is a critical need for detection methods that yield much
sooner diagnoses of infarction or rather possibilities of infarction.

Installing a system to separate plasma from whole blood.
Installing a system to include prepared reagents.
Optimizing channels for better mixing and incubation times.
Reverse engineering a portable luminometer to detect
chemiluminescence on the LOC.
Installing a digital display to output YES or NO result.

The device will contain a multilayered microfluidic lab-on-chip (Figure 3)
where the assay will be run.
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Figure 3. Top view diagram (left) and photo (right) of lab-on-chip design.

•

Plasma and assay reagents enter the device through circular inlet ports.
Solutions mix within micromixing channels (pleated arrow pattern).
Reaction products feed into an Archimedean spiral which amplifies the
chemiluminescent signal for detection using a luminometer [3].
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